Interestingly, the risk of adverse pregnancy outcomes in women with MAFLD remained significant despite adjusting for surrogate markers of insulin resistance (i.e., HOMA-IR, adiponectin and selenoprotein P levels), suggesting that the relationship between MAFLD and adverse pregnancy outcomes is likely mediated by other mechanisms than insulin resistance alone [14]. The gene discussed is SELENOP; the disease is Insulin resistance.